🕵️ Edgewell Personal Care Co ($EPC)
SEC insider & ownership activity, last 12 months · CIK 1096752 · every row links its SEC filing
Over the last 12 months insiders sold $6K with no open-market buying against it. John M. Dunham sold $6K in discretionary trades (Nov). Brandes Investment Partners, LP added 10.9% → 14.4%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $6K (1 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| John M. Dunham | 0 | – | 1 | $6K | Nov 20, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Blackrock, Inc. | 14.9% | 13G | Apr 30, 2025 | filing ↗ | |
| Brandes Investment Partners, LP | 14.4% | 13G | May 14, 2026 | filing ↗ | |
| American Century Investment Management, Inc. | 11.0% | 13G | Jun 5, 2026 | filing ↗ | |
| American Century Companies, Inc. | 11.0% | 13G | Jun 5, 2026 | filing ↗ | |
| Stowers Institute for Medical Research | 11.0% | 13G | Jun 5, 2026 | filing ↗ | |
| Rubric Capital Management LP | 8.6% | 13G | May 15, 2026 | filing ↗ | |
| David Rosen | 8.6% | 13G | May 15, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 6.6% | 13G | Apr 29, 2026 | filing ↗ | |
| American Century Capital Portfolios, Inc. | 5.8% | 13G | Jun 5, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.1% | 13G | Apr 29, 2026 | filing ↗ | |
| Dimensional Fund Advisors LP | exited | 13G | Jul 14, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Officer/director changes (5.02) | May 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | May 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 6, 2026 | filing ↗ |
| Earnings (2.02) | Feb 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Feb 5, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 5, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Feb 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Feb 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 2, 2026 | filing ↗ |
| Earnings (2.02) | Nov 13, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 13, 2025 | filing ↗ |
| Material agreement (1.01) | Nov 12, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 12, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 12, 2025 | filing ↗ |
| Officer/director changes (5.02) | Aug 29, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 29, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 29, 2025 | filing ↗ |
| Earnings (2.02) | Aug 5, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 5, 2025 | filing ↗ |